Current clinical challenges in Hodgkin lymphoma (HL) include difficult-to-treat relapsed/refractory disease and considerable long-term toxicities of treatment. Since clinical risk factors lack ...
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...
Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...
Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. In 1976, workers excavating a tunnel for the Toronto subway system ...
When it comes to finding answers, every moment counts—especially in critical care settings like the neonatal and pediatric intensive care units (NICU and PICU). Although rapid genetic tests, whether ...
Select Agents (SAs) are listed dangerous bacteria, viruses, toxins, and fungi. However, natural variation and intentional genetic modification blur the boundaries of a Select Agent list based on names ...
Newborn babies admitted to the hospital's neonatal intensive care unit (NICU) rely on the quick decisions and rapid action of the medical team responsible for them. DNA testing is critical to ...
The article by Heger et al entitled “Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma” (J Clin Oncol 10.1200/JCO.23 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback